Our data for the first time demonstrates that inhibition of the Nox‐4 associated pro‐survival signaling pathway by shikonin enhances the anti‐proliferative and anti‐angiogenic potential of 2‐DG in GBM cells. Here, NOX4 is linked to glioblastoma.